Skip to content
AnalystLens

Leidos Holdings 8-K Report, Financial Results (Apr 30, 2024)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed April 30, 2024
Period End
April 30, 2024
Security
LDOS
In the record · 2016–202610-K1210-Q338-K130

LDOS filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 130 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Aug ’17Aug ’17
  2. Leadership change8-K · Mar ’20Mar ’20
  3. Leadership change8-K · Feb ’22Feb ’22
  4. Material agreement8-K · Oct ’26Oct ’26

Summary

Summary of the 8-K filed April 30, 2024. Cited figures are marked; the original filing is the authoritative source.

Leidos Holdings, Inc. reported first-quarter fiscal 2024 results for the quarter ended March 29, 2024, in a press release furnished as Exhibit 99.1 to this Form 8-K.

Revenues were $3,975 milliona, up 7% from $3,699 million a year earlier, driven by increased demand across all customer segments, especially managed health services. Net income rose to $283 million, or $2.07 per diluted share, from $164 million, or $1.17 per diluted share. Adjusted EBITDA was $490 million, a 12.3% margin compared with 9.4% in the prior-year quarter, and non-GAAP diluted EPS was $2.29, up 56% year-over-year.

The company attributed the profitability gains primarily to higher volumes on fixed-rate managed health services and improved cost control. Cash generation and capital returns were mixed in the quarter. Net cash provided by operating activities was $63 millionb and non-GAAP free cash flow was $46 million, compared with a use of $98 million in operating cash flow in the prior-year quarter.

Leidos returned $236 millionc to shareholders, including $183 million in share repurchases and $53 million in dividends. Net bookings were $3.7 billion, a book-to-bill ratio of 0.9 for the quarter and 1.1 for the trailing twelve months, and backlog ended the quarter at $36.6 billion, of which $8.0 billion was funded. The company raised its fiscal 2024 guidance for revenues, adjusted EBITDA margin, non-GAAP diluted EPS and operating cash flow, and declared a quarterly dividend of $0.38 per share payable June 28, 2024.

Key Highlights

  1. Revenue of $3,975 million rose 7% year-over-year, with Health & Civil up 19% to $1.20 billion and National Security and Digital up 2% to $1.79 billion.
  2. Net income of $283 million ($2.07 per diluted share) compared with $164 million ($1.17) in the prior-year quarter; net income margin was 7.1% versus 4.4%.
  3. Adjusted EBITDA of $490 million reached a 12.3% margin, up from 9.4%, and non-GAAP diluted EPS was $2.29, up 56% year-over-year.
  4. Health & Civil operating income margin improved to 18.5% from 11.2%, driven by increased volumes and case complexity in managed health services.
  5. Fiscal 2024 guidance was raised: revenues to $16.0–$16.4 billion, adjusted EBITDA margin to mid-to-high 11%, non-GAAP diluted EPS to $8.40–$8.80, and operating cash flow to approximately $1.3 billion.
  6. Net bookings were $3.7 billion (book-to-bill 0.9 for the quarter, 1.1 trailing twelve months), with backlog of $36.6 billion, of which $8.0 billion was funded.
  7. Leidos repurchased $183 million of stock and paid $53 million in dividends in the quarter, and declared a $0.38 per share dividend payable June 28, 2024.

Frequently Asked Questions

  1. What drove the improvement in Leidos's profitability this quarter?

    The company said the primary drivers were increased volumes on fixed-rate managed health services and improved cost control across the company. Health & Civil operating income rose to $222 million from $113 million, and National Security and Digital operating income rose to $175 million from $145 million.

  2. How much did Leidos change its fiscal 2024 guidance?

    Leidos raised revenue guidance to $16.0–$16.4 billion from $15.7–$16.1 billion, adjusted EBITDA margin to mid-to-high 11% from mid-to-high 10%, non-GAAP diluted EPS to $8.40–$8.80 from $7.50–$7.90, and operating cash flow to approximately $1.3 billion from approximately $1.1 billion. The CEO said greater visibility around customer funding and performance was behind the raise.

  3. How strong is Leidos's order intake and backlog?

    Net bookings were $3.7 billion in the quarter, a book-to-bill ratio of 0.9, while the trailing twelve-month book-to-bill was 1.1. Total backlog was $36.6 billion at quarter-end, of which $8.0 billion was funded and $28.6 billion was unfunded.

  4. What is Leidos's cash position and how is it returning capital?

    As of March 29, 2024, Leidos had $633 million in cash and cash equivalents and $4.7 billion of debt. In the quarter it returned $236 million to shareholders, including $183 million in share repurchases and $53 million in dividends, and its Board declared a $0.38 per share dividend payable June 28, 2024.